We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walgreens (WBA) May Buy Remaining Stake in AmerisourceBergen
Read MoreHide Full Article
Per a report in The Wall Street Journal, Walgreens Boots Alliance, Inc. (WBA - Free Report) is in early-stage talks to buy the remaining stake in the leading pharmaceutical services company, AmerisourceBergen Corporation . Soon after the takeover rumor surfaced on Feb 12, shares of AmerisourceBergen gained 15.7% in after-hours trading and subsequently, closed with a 0.3% rise. However, the stock price of Walgreens remained unchanged.
In this regard, we remind investors that the drugstore retailer and pharmacy-led, health and wellbeing enterprise already holds a 26% stake in AmerisourceBergen, which is part of their long-term strategic relationship, formed in 2013. That relationship comprises a 10-year pharmaceutical distribution contract with AmerisourceBergen.
We believe, Walgreen’s latest decision to acquire AmerisourceBergen’s remaining stake, comes close on the heels of its rival CVS Health’s (CVS - Free Report) gigantic $69-billion acquisition deal of health insurer, Aetna Inc . According to a Reuters report, the Walgreens-AmerisourceBergen integration, similar to the CVS-Aetna deal, is likely to move toward a vertical consolidation, combining all members of a supply chain.
This apart, some analysts believe that this move may be in response to Amazon’s latest decision to step into the multibillion-dollar pharmaceutical industry. Notably, in December 2017, Amazon.com, Inc (AMZN - Free Report) had acquired pharmacy licenses in a dozen states.
As far as the news revolving around Walgreens-AmerisourceBergen agreement is concerned, many market researchers view this takeover rumor to be strategic, although the companies themselves have remained silent on this speculative issue.
Significantly, Walgreens has a market capitalization of $67.82 billion while the same for AmerisourceBergen remains at $19.65 billion.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Walgreens (WBA) May Buy Remaining Stake in AmerisourceBergen
Per a report in The Wall Street Journal, Walgreens Boots Alliance, Inc. (WBA - Free Report) is in early-stage talks to buy the remaining stake in the leading pharmaceutical services company, AmerisourceBergen Corporation . Soon after the takeover rumor surfaced on Feb 12, shares of AmerisourceBergen gained 15.7% in after-hours trading and subsequently, closed with a 0.3% rise. However, the stock price of Walgreens remained unchanged.
In this regard, we remind investors that the drugstore retailer and pharmacy-led, health and wellbeing enterprise already holds a 26% stake in AmerisourceBergen, which is part of their long-term strategic relationship, formed in 2013. That relationship comprises a 10-year pharmaceutical distribution contract with AmerisourceBergen.
Walgreens Boots Alliance, Inc. Price
Walgreens Boots Alliance, Inc. Price | Walgreens Boots Alliance, Inc. Quote
We believe, Walgreen’s latest decision to acquire AmerisourceBergen’s remaining stake, comes close on the heels of its rival CVS Health’s (CVS - Free Report) gigantic $69-billion acquisition deal of health insurer, Aetna Inc . According to a Reuters report, the Walgreens-AmerisourceBergen integration, similar to the CVS-Aetna deal, is likely to move toward a vertical consolidation, combining all members of a supply chain.
This apart, some analysts believe that this move may be in response to Amazon’s latest decision to step into the multibillion-dollar pharmaceutical industry. Notably, in December 2017, Amazon.com, Inc (AMZN - Free Report) had acquired pharmacy licenses in a dozen states.
As far as the news revolving around Walgreens-AmerisourceBergen agreement is concerned, many market researchers view this takeover rumor to be strategic, although the companies themselves have remained silent on this speculative issue.
Significantly, Walgreens has a market capitalization of $67.82 billion while the same for AmerisourceBergen remains at $19.65 billion.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>